View in EDS HTML Full Text PDF Full Text

Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial.

Saved in:
Bibliographic Details
Title: Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial.
Authors: Catlett, Ian M.1 (AUTHOR), Gao, Lu1 (AUTHOR) Lu.Gao@bms.com, Hu, Yanhua1 (AUTHOR), Banerjee, Subhashis1 (AUTHOR), Krueger, James G.2 (AUTHOR)
Source: Dermatology & Therapy. Oct2024, Vol. 14 Issue 10, p2827-2839. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 180269110
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Catlett%2C+Ian+M%2E%22">Catlett, Ian M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gao%2C+Lu%22">Gao, Lu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> Lu.Gao@bms.com</i><br /><searchLink fieldCode="AR" term="%22Hu%2C+Yanhua%22">Hu, Yanhua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Banerjee%2C+Subhashis%22">Banerjee, Subhashis</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krueger%2C+James+G%2E%22">Krueger, James G.</searchLink><relatesTo>2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Dermatology+%26+Therapy%22">Dermatology & Therapy</searchLink>. Oct2024, Vol. 14 Issue 10, p2827-2839. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180269110
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13555-024-01262-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 2827
    Titles:
      – TitleFull: Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Catlett, Ian M.
      – PersonEntity:
          Name:
            NameFull: Gao, Lu
      – PersonEntity:
          Name:
            NameFull: Hu, Yanhua
      – PersonEntity:
          Name:
            NameFull: Banerjee, Subhashis
      – PersonEntity:
          Name:
            NameFull: Krueger, James G.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 21938210
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Dermatology & Therapy
              Type: main
ResultId 1